首页 | 本学科首页   官方微博 | 高级检索  
     

溶血磷脂酸对子宫内膜癌RL-952细胞尿激酶型纤溶酶原激活剂分泌的影响
引用本文:周敬伟,张果,赵丽君,李小平,王建六,魏丽惠. 溶血磷脂酸对子宫内膜癌RL-952细胞尿激酶型纤溶酶原激活剂分泌的影响[J]. 中国妇产科临床杂志, 2012, 13(4): 291-293
作者姓名:周敬伟  张果  赵丽君  李小平  王建六  魏丽惠
作者单位:100044,北京大学人民医院妇产科
基金项目:国家自然基金(C30973181)
摘    要:目的探讨溶血磷脂酸(lysophosphatidic acid,LPA)对子宫内膜癌RL-952细胞尿激酶型纤溶酶原激活剂(urokinase-type plasminogen activator,uPA)分泌的影响。方法不同浓度的LPA刺激子宫内膜癌RL-952细胞24h,80μmol/LLPA刺激子宫内膜癌RL-952细胞不同时间后收集细胞上清液,采用酶联免疫吸附试验检测uPA的分泌情况,Transwell试验检测LPA对子宫内膜癌RL-952细胞体外迁移/侵袭能力的影响。结果 2、10μmol/L的LPA即可诱导子宫内膜癌RL-952细胞uPA的分泌增加,且随着LPA浓度的加大,uPA分泌量明显增多,二者呈明显的浓度依赖关系;80μmol/L的LPA作用于RL-952细胞时,随着时间的延长uPA分泌量增多,二者呈明显的时间依赖关系。并且LPA可以明显增加子宫内膜癌RL-952细胞的体外迁移/侵袭能力。结论 LPA可成为子宫内膜癌早期诊断及预后监测的分子标志物,并有望成为子宫内膜癌分子靶向治疗的靶标。

关 键 词:溶血磷脂酸  子宫内膜癌  尿激酶型纤溶酶原激活剂  酶联免疫吸附试验  分子靶向治疗

The effect of urokinase-type plasminogen activator secretion on endometrial carcinoma RL-952 cell by stimulating of lysophosphatidic acid
ZHOU Jingwei , ZHANG Guo , ZHAO Lijun , LI Xiaoping , WANG Jianliu , WEI Lihui. The effect of urokinase-type plasminogen activator secretion on endometrial carcinoma RL-952 cell by stimulating of lysophosphatidic acid[J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2012, 13(4): 291-293
Authors:ZHOU Jingwei    ZHANG Guo    ZHAO Lijun    LI Xiaoping    WANG Jianliu    WEI Lihui
Affiliation:. (Department of Obstetric and Gynecolog,Peking University People’s Hospital,Beijing100044,China)
Abstract:Objective To investigate the effect of urokinase-type plasminogen activator(uPA) secretion on endometrial carcinoma RL-952cell by stimulating of lysophosphatidic acid(LPA).Methods Supernatant of endo-metrial carcinoma RL-952 cells was collected after stimulating with determined concentrations of LPA for 24hours or with 80μmol/L LPA at determined times,levels of urokinase-type plasminogen activator(uPA)in these super-natant were determined by enzyme labeled immunosorbent assay(ELISA).Transwell chamber assay was used to detect the migration/invasion abilities.Results 2μmol/L,10μmol/L concentrations of LPA can induce uPA secretion,and with the concentration increasing,the uPA production increased significantly which showed obvious con-centration-dependent,and also it showed significant time-dependent.The LPA significantly increased the migration/ invasion of endometrial cancer RL-952cells.Conclusions LPA is expected to become the molecular markers,the LPA receptor and its signaling pathway is expected to become the target of the molecular therapy of endometrial cancer.
Keywords:lysophosphatidic acid  endometrial carcinoma  urokinase-type plasminogen activator  enzyme-linked immunosorbent assay  molecular targeted therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号